WHO ICTRP trial
Effects of nanocurcumin in the treatment of non-alcoholic fatty liver disease
IRCT2016071915536N3 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2016071915536N3 |
|---|---|
| Public title | Effects of nanocurcumin in the treatment of non-alcoholic fatty liver disease |
| Scientific title | The clinical trial of effects of nanocurcumin supplementation on blood nesfatin, insulin resistance indexes, lipids and inflammatory factors in overweight and obese patients with non-alcoholic fatty liver disease ??(NAFLD)? |
| Primary sponsor | Vice chancellor for research, Tehran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Non alcoholic fatty liver disease. Nonalcoholic steatohepatitis, Nonalcoholic fatty liver disease;K75.8, K76;Nonalcoholic steatohepatitis, Nonalcoholic fatty liver disease |
| Interventions | Intervention 1: Intervention Group: Nanocurcumin supplementation with dose of 80mg (40mg bid with breakfast and dinner meals) for 3 months. Intervention 2: Placebo Group: Placebo supplementation with dose of 80mg (40mg bid with breakfast… |
| Registration date | Aug 2, 2016 |
| Target size | 84 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: